Small Business Innovation Research (SBIR) program, Phase I
ID: 355620Type: Posted
Overview

Buyer

Administration for Community Living (HHS-ACL)

Award Range

$95K - $100K

Eligible Applicants

Small Businesses

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/355620

Additional Information

https://www.acl.gov/grants/applying-grants
Timeline
    Description

    The Administration for Community Living is offering a Small Business Innovation Research (SBIR) program, Phase I grant aimed at stimulating technological innovation in the private sector, particularly to enhance the lives of individuals with disabilities. Eligible small businesses are invited to conduct research to assess the scientific or technical merit and feasibility of their concepts, with the goal of increasing the commercial application of research results supported by the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR). This opportunity includes a total estimated funding of $1,100,000, with individual grants ranging from $95,000 to $100,000, and a project period of six months. Interested applicants must submit their proposals electronically by December 16, 2024, and can reach out to Brian Bard at brian.bard@acl.hhs.gov for further information.

    Point(s) of Contact
    brian.bard@acl.hhs.gov
    Files
    No associated files provided.
    Similar Opportunities
    National Paralysis Initiative
    Administration for Community Living
    The Administration for Community Living is forecasting a funding opportunity titled the National Paralysis Initiative, aimed at improving the health and quality of life for individuals living with paralysis and their support systems. This initiative seeks to enhance independence, create stronger support networks, and increase community participation for affected individuals through various funded activities. With an estimated total program funding of $1,185,000, the agency plans to award three cooperative agreements, each ranging from $350,000 to $400,000, with applications expected to be accepted starting March 1, 2022, and closing on May 2, 2022. Interested applicants can reach out to Elizabeth Leef at elizabeth.leef@acl.hhs.gov or (202) 475-2482 for further information.
    Projects of National Significance: Empowering Individuals
    Administration for Community Living
    The Administration for Community Living is forecasting a funding opportunity titled "Projects of National Significance: Empowering Individuals," aimed at enhancing the lives of individuals with intellectual and developmental disabilities (ID/DD) and their families. This initiative, supported by the Developmental Disabilities Assistance and Bill of Rights Act, seeks to empower these individuals through policy advocacy, leadership development, and increased knowledge of available supports, ultimately fostering their full participation in community life. The program anticipates awarding five cooperative agreements, with funding amounts ranging from $300,000 to $375,000, totaling an estimated $1,875,000, and interested applicants must be private institutions of higher education or eligible faith-based and community organizations. For further details, applicants can contact Larissa Crossen at (202) 795-7333 or via email at larissa.crossen@acl.hhs.gov, with proposals expected to be submitted between March 31, 2024, and May 30, 2024, and awards anticipated by September 1, 2024.
    Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity aimed at advancing research on Alzheimer's Disease (AD) and AD-related dementias (ADRD) through the Small Business Innovation Research (SBIR) program. This initiative invites U.S. small businesses to submit applications for innovative research projects that could lead to new therapies, diagnostic technologies, or prevention strategies for AD/ADRD. The funding reflects a significant federal commitment to addressing the challenges posed by these conditions, with a total of $20 million anticipated for approximately 40 awards in 2023, providing up to $500,000 for Phase I and $2.5 million for Phase II projects. Interested applicants can find more details and application requirements at the provided link and should note that the application deadline is September 5, 2025. For inquiries, contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    PNS: Empowering Individuals
    Administration for Community Living
    The Administration for Community Living is forecasting a grant opportunity titled "PNS: Empowering Individuals," aimed at supporting projects that empower individuals with intellectual and developmental disabilities (ID/DD) and their families. The initiative seeks to fund projects of national significance that enhance community participation, self-determination, and policy advocacy for individuals with ID/DD, with a total estimated program funding of $10 million and individual awards ranging from $300,000 to $1 million. Eligible applicants include private institutions of higher education and nonprofit entities, with a total of five awards expected to be made. Interested parties can find additional information and contact Larissa Crossen at larissa.crossen@acl.hhs.gov or (202) 795-7333, with applications anticipated to be accepted from February 28, 2023, to April 28, 2023.
    NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required)" aimed at supporting Small Business Concerns (SBCs) in conducting investigator-initiated exploratory clinical trials related to neurological disorders. This initiative encourages applications for Phase I and II studies focusing on drugs, biologics, devices, and therapies that align with the mission of the National Institute of Neurological Disorders and Stroke (NINDS), emphasizing the inclusion of a Plan for Enhancing Diverse Perspectives (PEDP) to foster innovation. The maximum funding amounts are $295,924 for Phase I and $1,972,828 for Phase II projects, with applications required to demonstrate readiness for eventual FDA regulatory approval. Interested applicants can begin submitting proposals on December 5, 2023, with the application deadline set for September 5, 2026; for further inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    Projects of National Significance: Achieving Economic Mobility
    Administration for Community Living
    The Administration for Community Living is forecasting a funding opportunity titled "Projects of National Significance: Achieving Economic Mobility," aimed at enhancing economic security and mobility for individuals with intellectual and developmental disabilities. The initiative seeks to support projects that may include aiding the transition of youth with disabilities, funding employment and postsecondary education opportunities, and providing assistive technology devices to help meet employment goals. This funding is critical for fostering inclusion and self-determination among individuals with developmental disabilities, with a total estimated program funding of $1,875,000 available for five awards, each ranging from $300,000 to $375,000. Interested applicants, specifically private institutions of higher education and eligible faith-based organizations, should note that the estimated synopsis post date is March 29, 2024, with applications closing on May 28, 2024. For further inquiries, contact Larissa Crossen at (202) 795-7333 or via email at larissa.crossen@acl.hhs.gov.
    Projects of National Significance: Achieving Economic Mobility
    Administration for Community Living
    The Administration for Community Living is forecasting a funding opportunity titled "Projects of National Significance: Achieving Economic Mobility," aimed at enhancing economic security and mobility for individuals with intellectual and developmental disabilities. This initiative seeks to support projects that may include aiding youth transitions, funding employment and post-secondary education opportunities, and providing assistive technology to help achieve employment goals. The total estimated program funding is $1,875,000, with awards ranging from $300,000 to $375,000, and approximately five awards are expected to be made. Interested applicants, specifically private institutions of higher education and eligible faith-based and community organizations, can find more information and contact Larissa Crossen at larissa.crossen@acl.hhs.gov, with applications anticipated to be open from May 30, 2025, to July 30, 2025.
    Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities," aimed at supporting U.S. small businesses in developing innovative technologies, products, or services that address health disparities among minority populations. Eligible applicants are encouraged to propose solutions that enhance healthcare delivery, promote health-seeking behaviors, and overcome barriers in minority health, with funding available through the Small Business Innovation Research (SBIR) program for both Phase I and II grants. This initiative underscores the government's commitment to advancing health equity and leveraging small business innovation to tackle significant healthcare challenges faced by underserved communities. Applications are due by December 10, 2026, and interested parties can find more information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) have announced the PHS 2024-2 Omnibus Solicitation for Small Business Innovation Research (SBIR) grant applications, specifically requiring clinical trials. This funding opportunity is aimed at U.S. small businesses with the necessary research capabilities to contribute to the missions of the NIH and CDC, encouraging innovation and the commercial viability of health technologies. Eligible applicants can receive funding up to $306,872 for Phase I and $2,045,816 for Phase II, with a submission deadline of April 5, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PA-24-246.html.
    Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the "Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD)" funding opportunity, aimed at supporting innovative research projects that focus on the prevention, diagnosis, treatment, and care for individuals affected by these conditions. This initiative, part of the Small Business Technology Transfer Research (STTR) program, encourages the development of new therapies, devices, and healthcare programs, with an estimated $4 million allocated for approximately ten grants, including maximum budgets of $500,000 for Phase I and $2.5 million for Phase II awards. The funding opportunity underscores the federal commitment to addressing Alzheimer's research challenges through collaboration and innovation in the biomedical field. Interested applicants can find more information and application guidelines at the provided link, with the closing date for submissions set for September 5, 2025.